Viewing Study NCT05557695


Ignite Creation Date: 2025-12-24 @ 2:12 PM
Ignite Modification Date: 2025-12-26 @ 7:10 AM
Study NCT ID: NCT05557695
Status: RECRUITING
Last Update Posted: 2025-12-11
First Post: 2022-08-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module